US Patent 11161852 Inhibitors of NEK7 kinase

Patent 11161852 was granted and assigned to Halia Therapeutics, Inc. on November, 2021 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

November 2, 2021

Patent Application Number

20210507

Date Filed

May 7, 2021

Patent Citations Received

Patent abstract

Compounds having activity as inhibitors of NEK7 are provided. The compounds have Structure (I):

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11161852 Inhibitors of NEK7 kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.